MICHELE BURGESS

Allopathic & Osteopathic Physicians|Dermatology CHICAGO, IL NPI 1255435566

General Payments — all program years on this page

$3,825.35

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 140
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $889.47 across 41 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $881.0240
Education $8.451

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $797.833
2019 $42.912
2021 $195.735
2022 $939.8949
2023 $959.5240
2024 $889.4741

Records — PY2024 (41)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1084915124 Hologic Sales and Service, LLC $19.41 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086677229 Novartis Pharmaceuticals Corporation $23.78 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086677231 Novartis Pharmaceuticals Corporation $26.37 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086677233 Novartis Pharmaceuticals Corporation $25.65 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086677235 Novartis Pharmaceuticals Corporation $21.35 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086677237 Novartis Pharmaceuticals Corporation $26.73 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100056443 Journey Medical Corporation $15.06 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103392157 ABBVIE INC. $28.69 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103392159 ABBVIE INC. $7.78 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103392161 ABBVIE INC. $9.46 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103392163 ABBVIE INC. $29.46 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103392165 ABBVIE INC. $16.84 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103392167 ABBVIE INC. $19.31 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103392169 ABBVIE INC. $32.63 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103392171 ABBVIE INC. $8.47 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103392173 ABBVIE INC. $19.70 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103392175 ABBVIE INC. $17.47 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103392177 ABBVIE INC. $6.64 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103392179 ABBVIE INC. $2.28 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103392181 ABBVIE INC. $18.44 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104194634 ABBVIE INC. $8.45 04/17/2024 Education Undisputed 01/23/2026 View at CMS
1114016586 Regeneron Healthcare Solutions, Inc. $27.58 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114016588 Regeneron Healthcare Solutions, Inc. $24.85 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139768280 GENZYME CORPORATION $32.04 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139768288 GENZYME CORPORATION $26.99 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139768302 GENZYME CORPORATION $27.18 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139768312 GENZYME CORPORATION $28.70 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141183532 Incyte Corporation $26.02 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141218870 Incyte Corporation $25.59 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141258441 Incyte Corporation $24.10 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141259341 Incyte Corporation $19.67 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141294930 Incyte Corporation $23.42 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141295100 Incyte Corporation $27.16 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141295150 Incyte Corporation $25.77 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141322021 Incyte Corporation $27.12 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145288373 Galderma Laboratories, L.P. $18.44 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145288375 Galderma Laboratories, L.P. $22.85 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152622243 LEO Pharma Inc. $24.72 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152622245 LEO Pharma Inc. $26.97 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152622247 LEO Pharma Inc. $24.91 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153814561 Ortho Dermatologics, a division of Bausch Health US, LLC $21.42 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.